Shield Therapeutics Market Cap

Shield Therapeutics has a market cap or net worth of 18.38 million as of April 17, 2025. Its market cap has increased by 42.42% in one year.

Market Cap

18.38M

Enterprise Value

27.77M

Revenue

16.99M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.35

Market Cap Chart

Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 18.38M, a decrease of -89.17%. That is a compound annual growth rate of -21.58%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2025	18.38M	-12.96%
Dec 31, 2024	21.12M	-59.70%
Dec 29, 2023	52.40M	186.53%
Dec 30, 2022	18.29M	-80.96%
Dec 31, 2021	96.06M	28.62%
Dec 31, 2020	74.69M	-64.39%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	159.41B
GSK plc	54.59B
Haleon	34.17B
Smith & Nephew	8.68B
ConvaTec Group	5.29B
Hikma Pharmaceuticals	4.20B
HUTCHMED (China)	1.86B
Oxford Nanopore Technologies	1.19B

Market Cap Rankings